{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:37:50Z","timestamp":1789756670664,"version":"4.0.1"},"reference-count":160,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002567","name":"American Academy of Allergy Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.iac.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T09:13:06Z","timestamp":1591693986000},"page":"437-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Chronic Lung Disease in Primary Antibody Deficiency"],"prefix":"10.1016","volume":"40","author":[{"given":"Paul J.","family":"Maglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2020.03.003_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.humimm.2018.10.015","article-title":"Primary B-cell immunodeficiencies","volume":"80","author":"Smith","year":"2019","journal-title":"Hum Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3466","article-title":"Primary antibody deficiencies","volume":"13","author":"Durandy","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib3","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2012.03.025","article-title":"Common variable immunodeficiency","volume":"129","author":"Cunningham-Rundles","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jaip.2016.08.005","article-title":"Lung disease in primary antibody deficiencies","volume":"4","author":"Schussler","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2020.03.003_bib5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fimmu.2018.00694","article-title":"Delayed diagnosis and complications of predominantly antibody deficiencies in a cohort of Australian adults","volume":"9","author":"Slade","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7861\/clinmedicine.9-6-595","article-title":"Primary antibody deficiencies: recognition, clinical diagnosis and referral of patients","volume":"9","author":"Wood","year":"2009","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.iac.2020.03.003_bib7","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.anai.2010.04.015","article-title":"Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors","volume":"104","author":"Gregersen","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0091-6749(91)90306-9","article-title":"Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia","volume":"88","author":"Sweinberg","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1378\/chest.106.2.490","article-title":"Radiologic findings of adult primary immunodeficiency disorders. Contribution of CT","volume":"106","author":"Obregon","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.iac.2020.03.003_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1067\/mai.2002.124999","article-title":"Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency","volume":"109","author":"Busse","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ebiom.2017.03.025","article-title":"Long-term clinical outcome of antibody replacement therapy in humoral immunodeficient adults with respiratory tract infections","volume":"18","author":"van Kessel","year":"2017","journal-title":"EBioMedicine"},{"issue":"Suppl 3","key":"10.1016\/j.iac.2020.03.003_bib14","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1111\/trf.15020","article-title":"Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy","volume":"58","author":"Gernez","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.iac.2020.03.003_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.iac.2020.03.003_bib16","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.iac.2020.03.003_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies","volume":"144","author":"Milito","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaci.2010.04.016","article-title":"Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia","volume":"126","author":"Kainulainen","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib19","doi-asserted-by":"crossref","first-page":"e2049","DOI":"10.1002\/rmv.2049","article-title":"Viral infection in primary antibody deficiency syndromes","volume":"29","author":"Jones","year":"2019","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.iac.2020.03.003_bib20","doi-asserted-by":"crossref","first-page":"E322","DOI":"10.1111\/1469-0691.12193","article-title":"Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia","volume":"19","author":"Peltola","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.iac.2020.03.003_bib21","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaci.2011.03.041","article-title":"Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies","volume":"127","author":"Chen","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib22","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.iac.2020.03.003_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000101784","article-title":"Genetic causes of bronchiectasis: primary immune deficiencies and the lung","volume":"74","author":"Notarangelo","year":"2007","journal-title":"Respiration"},{"issue":"Suppl A","key":"10.1016\/j.iac.2020.03.003_bib24","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/S1526-0542(04)90043-7","article-title":"Pulmonary complications of primary immunodeficiencies","volume":"5","author":"Buckley","year":"2004","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.iac.2020.03.003_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","article-title":"The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial","volume":"135","author":"Eijkhout","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2020.03.003_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0090-1229(86)90070-X","article-title":"Infectious complications of the primary immunodeficiencies","volume":"40","author":"Stiehm","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.iac.2020.03.003_bib27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJM196610132751508","article-title":"The gamma globulins. IV. Therapeutic uses of gamma globulin","volume":"275","author":"Janeway","year":"1966","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2020.03.003_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cei.13068","article-title":"Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy","volume":"191","author":"Stubbs","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/clim.2002.5241","article-title":"Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study","volume":"104","author":"Plebani","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-016-0597-6","article-title":"Autoimmune and lymphoproliferative complications of common variable immunodeficiency","volume":"16","author":"Maglione","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.iac.2020.03.003_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1440-1843.2009.01679.x","article-title":"Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia","volume":"15","author":"Aghamohammadi","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.iac.2020.03.003_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10875-019-00640-5","article-title":"Factors beyond lack of antibody govern pulmonary complications in primary antibody deficiency","volume":"39","author":"Weinberger","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.bor.0000231905.12172.b5","article-title":"Hyper-IgM syndromes","volume":"18","author":"Durandy","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.iac.2020.03.003_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/cei.13012","article-title":"Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group","volume":"190","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib36","first-page":"122","article-title":"Evaluation of pulmonary complications in patients with primary immunodeficiency disorders","volume":"49","author":"Reisi","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000494128","article-title":"Bronchial asthma and bronchial hyperresponsiveness and their characteristics in patients with common variable immunodeficiency","volume":"178","author":"Milota","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib38","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","article-title":"Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets","volume":"8","author":"Farmer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.aller.2013.09.014","article-title":"Bronchial hyperreactivity in children with antibody deficiencies","volume":"43","author":"Ozcan","year":"2015","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.iac.2020.03.003_bib40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.mayocp.2013.05.021","article-title":"Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study","volume":"88","author":"Urm","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.iac.2020.03.003_bib41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1398-9995.2009.02211.x","article-title":"Allergic asthma in patients with common variable immunodeficiency","volume":"65","author":"Agondi","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2020.03.003_bib42","doi-asserted-by":"crossref","first-page":"e0172437","DOI":"10.1371\/journal.pone.0172437","article-title":"Antibody deficiency in patients with frequent exacerbations of chronic obstructive pulmonary disease (COPD)","volume":"12","author":"McCullagh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.iac.2020.03.003_bib43","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1164\/rccm.201604-0759OC","article-title":"Secretory IgA deficiency in individual small airways is associated with persistent inflammation and remodeling","volume":"195","author":"Polosukhin","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2020.03.003_bib44","doi-asserted-by":"crossref","first-page":"e0194924","DOI":"10.1371\/journal.pone.0194924","article-title":"Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS","volume":"13","author":"Putcha","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.iac.2020.03.003_bib45","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10875-014-0068-6","article-title":"CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters","volume":"34","author":"Maarschalk-Ellerbroek","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib46","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1097\/00006454-198805001-00017","article-title":"Replacement therapy with high dose intravenous gamma-globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia","volume":"7","author":"Roifman","year":"1988","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.iac.2020.03.003_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.alit.2019.10.011","article-title":"Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency","volume":"69","author":"Tiotiu","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.iac.2020.03.003_bib48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4168\/aair.2017.9.6.526","article-title":"Effects of immunoglobulin replacement on asthma exacerbation in adult asthmatics with IgG subclass deficiency","volume":"9","author":"Kim","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.iac.2020.03.003_bib49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jama.2019.0131","article-title":"Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review","volume":"321","author":"Riley","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.iac.2020.03.003_bib50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.mcna.2018.12.004","article-title":"Asthma in the primary care setting","volume":"103","author":"Wu","year":"2019","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.iac.2020.03.003_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.iac.2020.03.003_bib52","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMra012519","article-title":"Bronchiectasis","volume":"346","author":"Barker","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2020.03.003_bib53","first-page":"6","article-title":"Inflammation: a two-edged sword\u2014the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"10.1016\/j.iac.2020.03.003_bib54","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/alr.22436","article-title":"Prevalence and characterization of chronic rhinosinusitis in patients with non-cystic fibrosis bronchiectasis at a tertiary care center in the United States","volume":"9","author":"Somani","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.iac.2020.03.003_bib55","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.anai.2014.04.024","article-title":"Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations","volume":"113","author":"Maglione","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10875-018-0577-9","article-title":"Imaging of bronchial pathology in antibody deficiency: data from the European Chest CT Group","volume":"39","author":"Schutz","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10875-008-9229-9","article-title":"IgA deficiency: correlation between clinical and immunological phenotypes","volume":"29","author":"Aghamohammadi","year":"2009","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib59","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM198509193131203","article-title":"Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3","volume":"313","author":"Bjorkander","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2020.03.003_bib60","first-page":"703","article-title":"Serum IgG subclasses in chronic and recurrent respiratory infections","volume":"58","author":"Stanley","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib61","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/ajrccm.153.2.8564113","article-title":"IgG subclass deficiencies associated with bronchiectasis","volume":"153","author":"De Gracia","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2020.03.003_bib62","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1183\/09031936.05.00073204","article-title":"Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology","volume":"25","author":"van Kessel","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2020.03.003_bib63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10875-017-0381-y","article-title":"Low IgA and IgM is associated with a higher prevalence of bronchiectasis in primary antibody deficiency","volume":"37","author":"Hodkinson","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib64","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3389\/fimmu.2018.01925","article-title":"Limited innovations after more than 65 years of immunoglobulin replacement therapy: potential of IgA- and IgM-enriched formulations to prevent bacterial respiratory tract infections","volume":"9","author":"Langereis","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib65","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.iac.2020.03.003_bib66","first-page":"1155","article-title":"Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis","volume":"64","author":"Pereira","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.iac.2020.03.003_bib67","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mi.2016.18","article-title":"Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation","volume":"9","author":"Jorgensen","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan1217","article-title":"Microbial ecology perturbation in human IgA deficiency","volume":"10","author":"Fadlallah","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.iac.2020.03.003_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1081\/COPD-200050685","article-title":"Outcome in adult bronchiectasis","volume":"2","author":"King","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.iac.2020.03.003_bib70","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thx.2005.047332","article-title":"Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis","volume":"61","author":"Twiss","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2020.03.003_bib71","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Martinez-Garcia","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.iac.2020.03.003_bib72","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.crad.2011.10.028","article-title":"Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders","volume":"67","author":"Hampson","year":"2012","journal-title":"Clin Radiol"},{"key":"10.1016\/j.iac.2020.03.003_bib73","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10875-013-9942-x","article-title":"Activity, severity and impact of respiratory disease in primary antibody deficiency syndromes","volume":"34","author":"Hurst","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccm.2012.02.002","article-title":"Bronchiectasis and nontuberculous mycobacterial disease","volume":"33","author":"Griffith","year":"2012","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.iac.2020.03.003_bib75","first-page":"44","article-title":"Immunomodulatory effect of macrolides: at what cost?","volume":"17","author":"Kipourou","year":"2016","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.iac.2020.03.003_bib76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12931-019-1242-4","article-title":"Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center","volume":"20","author":"Goussault","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.iac.2020.03.003_bib77","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1183\/09031936.00119114","article-title":"Management of bronchiectasis in adults","volume":"45","author":"Chalmers","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2020.03.003_bib78","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.iac.2020.03.003_bib79","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","author":"Welsh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.iac.2020.03.003_bib80","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.iac.2020.03.003_bib81","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2020.03.003_bib82","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12879-015-0872-5","article-title":"Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials","volume":"15","author":"Fan","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.iac.2020.03.003_bib83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0035-1547346","article-title":"Inhaled antibiotics in cystic fibrosis (CF) and non-CF bronchiectasis","volume":"36","author":"Tay","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.iac.2020.03.003_bib84","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1513\/AnnalsATS.201806-368AW","article-title":"Emerging concepts and therapies for mucoobstructive lung disease","volume":"15","author":"Mall","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.iac.2020.03.003_bib85","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(15)00202-7","article-title":"Lung disease in primary antibody deficiency","volume":"3","author":"Verma","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.iac.2020.03.003_bib86","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70085-0","article-title":"Pulmonary abnormalities in patients with primary hypogammaglobulinemia","volume":"104","author":"Kainulainen","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib87","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaip.2015.07.004","article-title":"Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings","volume":"3","author":"Maglione","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2020.03.003_bib88","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.iac.2020.03.003_bib89","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","article-title":"Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency","volume":"110","author":"Quartier","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib90","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10875-013-9980-4","article-title":"First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes","volume":"34","author":"Cabral-Marques","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib91","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.aller.2010.12.003","article-title":"Pulmonary complications in patients with antibody deficiency","volume":"39","author":"Costa-Carvalho","year":"2011","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.iac.2020.03.003_bib92","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.molimm.2009.03.012","article-title":"Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study","volume":"46","author":"Toth","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib93","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10875-009-9341-5","article-title":"Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia","volume":"30","author":"Lee","year":"2010","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib94","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10875-016-0251-z","article-title":"X-Linked agammagobulinemia in a large series of North African patients: frequency, clinical features and novel BTK mutations","volume":"36","author":"Aadam","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2016.02.010","article-title":"Clinical and mutational features of X-linked agammaglobulinemia in Mexico","volume":"165","author":"Garcia-Garcia","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib96","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.iac.2020.03.003_bib97","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib98","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.iac.2020.03.003_bib99","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/pai.12890","article-title":"Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T\u00a0cells","volume":"29","author":"Deya-Martinez","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.iac.2020.03.003_bib101","first-page":"121","article-title":"Lymphoid hyperplasia of the lung and Evans' syndrome in IgA deficiency","volume":"106","author":"Roca","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2020.03.003_bib102","first-page":"69","article-title":"IgA and\/or IgG subclass deficiency in children with recurrent respiratory infections and its relationship with chronic pulmonary damage","volume":"15","author":"Ozkan","year":"2005","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib103","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000050475","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome","volume":"68","author":"Reichenberger","year":"2001","journal-title":"Respiration"},{"key":"10.1016\/j.iac.2020.03.003_bib104","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/j.sult.2013.05.002","article-title":"Lymphoproliferative lung disorders: a radiologic-pathologic overview. Part I: reactive disorders","volume":"34","author":"Carrillo","year":"2013","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.iac.2020.03.003_bib105","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s10875-011-9565-z","article-title":"Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events","volume":"31","author":"da Silva","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib106","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"133","author":"Ardeniz","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib107","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00330-011-2191-6","article-title":"Organizing pneumonia: a kaleidoscope of concepts and morphologies","volume":"21","author":"Roberton","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.iac.2020.03.003_bib108","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.humpath.2015.05.011","article-title":"Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency\u2014histologic and immunohistochemical analyses of 16 cases","volume":"46","author":"Rao","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.iac.2020.03.003_bib109","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-0032-1325156","article-title":"Lymphocytic interstitial pneumonia and other benign lymphoid disorders","volume":"33","author":"Tian","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.iac.2020.03.003_bib110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.5858\/134.5.691","article-title":"Update on nonneoplastic pulmonary lymphoproliferative disorders and related entities","volume":"134","author":"Guinee","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.iac.2020.03.003_bib111","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0034-1376862","article-title":"Sarcoidosis and common variable immunodeficiency: similarities and differences","volume":"35","author":"Verbsky","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.iac.2020.03.003_bib112","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaip.2019.08.012","article-title":"Serum B-cell maturation antigen (BCMA) levels differentiate primary antibody deficiencies","volume":"8","author":"Maglione","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2020.03.003_bib113","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20050381","article-title":"Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency","volume":"202","author":"Wheat","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2020.03.003_bib114","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0161-6420(03)00455-X","article-title":"Patient satisfaction and visual symptoms after laser in\u00a0situ keratomileusis","volume":"110","author":"Bailey","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.iac.2020.03.003_bib115","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm\/145.4_Pt_1.940","article-title":"Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in\u00a0situ hybridization","volume":"145","author":"Barbera","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"Suppl 7","key":"10.1016\/j.iac.2020.03.003_bib116","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1469-0691.12534","article-title":"Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients","volume":"20","author":"San-Juan","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.iac.2020.03.003_bib117","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-014-0052-1","article-title":"Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency","volume":"34","author":"Unger","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib118","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11908-019-0704-7","article-title":"Molecular diagnostic advances in transplant infectious diseases","volume":"21","author":"Young","year":"2019","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.iac.2020.03.003_bib119","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.mcp.0000208455.80725.2a","article-title":"Classification and approach to bronchiolar diseases","volume":"12","author":"Ryu","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.iac.2020.03.003_bib120","first-page":"214601","article-title":"A\u00a0case of follicular bronchiolitis as the histological counterpart to nodular opacities in bronchiectatic Mycobacterium avium complex disease","volume":"2012","author":"Wakamatsu","year":"2012","journal-title":"Case Rep Pulmonol"},{"key":"10.1016\/j.iac.2020.03.003_bib121","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cei.13343","article-title":"Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?","volume":"198","author":"Patel","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib122","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/RTI.0b013e318166d32f","article-title":"Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings","volume":"23","author":"Torigian","year":"2008","journal-title":"J\u00a0Thorac Imaging"},{"key":"10.1016\/j.iac.2020.03.003_bib123","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/RCT.0b013e3181cad9da","article-title":"Common variable immunodeficiency: computed tomography evaluation of bronchopulmonary changes including nodular lesions in 40 patients. Correlation with clinical and immunological data","volume":"34","author":"Bondioni","year":"2010","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2020.03.003_bib124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10875-016-0294-1","article-title":"Autoimmunity and primary immunodeficiency disorders","volume":"36","author":"Allenspach","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib125","article-title":"Interstitial lung disease in rheumatoid arthritis remains a challenge for clinicians","volume":"8","author":"Bendstrup","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.iac.2020.03.003_bib126","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fimmu.2019.01327","article-title":"Pulmonary manifestations of primary Sjogren's syndrome: underlying immunological mechanisms, clinical presentation, and management","volume":"10","author":"Gupta","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib127","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.iac.2020.03.003_bib128","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.iac.2020.03.003_bib129","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"Gamez-Diaz","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib131","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jaip.2019.04.011","article-title":"Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review","volume":"7","author":"Habibi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2020.03.003_bib132","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s10875-019-00677-6","article-title":"A\u00a0spectrum of clinical findings from ALPS to CVID: several novel LRBA defects","volume":"39","author":"Cagdas","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib133","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.iac.2020.03.003_bib134","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.iac.2020.03.003_bib135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.iac.2020.03.003_bib136","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T\u00a0cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib137","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaci.2013.08.022","article-title":"Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency","volume":"133","author":"Maglione","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/imm.12554","article-title":"Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues","volume":"147","author":"Jones","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.iac.2020.03.003_bib139","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","article-title":"Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients","volume":"33","author":"Boursiquot","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib141","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cei.12856","article-title":"FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)","volume":"187","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib142","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3389\/fphar.2018.01559","article-title":"Lymphoid interstitial pneumonia in common variable immune deficiency\u2014case report with disease monitoring in various therapeutic options: pleiotropic effects of rituximab regimens","volume":"9","author":"Zdziarski","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.iac.2020.03.003_bib143","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/thx.2004.029819","article-title":"Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins","volume":"61","author":"Arish","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2020.03.003_bib144","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1164\/ajrccm.154.5.8912776","article-title":"Bronchiolar disease in rheumatoid arthritis","volume":"154","author":"Hayakawa","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2020.03.003_bib145","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/rccm.200301-053SO","article-title":"Bronchiolar disorders","volume":"168","author":"Ryu","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2020.03.003_bib146","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.rmed.2007.07.032","article-title":"Follicular bronchiolitis in surgical lung biopsies: clinical implications in 12 patients","volume":"102","author":"Aerni","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.iac.2020.03.003_bib147","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0091-6749(82)90066-5","article-title":"Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy","volume":"70","author":"Kohler","year":"1982","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib148","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thorax.55.1.88","article-title":"Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A","volume":"55","author":"Davies","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2020.03.003_bib149","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1081-1206(10)61228-8","article-title":"Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature","volume":"95","author":"Thatayatikom","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib150","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s10875-014-0079-3","article-title":"Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency","volume":"34","author":"Franxman","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib151","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/bjc.2014.523","article-title":"Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study","volume":"112","author":"Chien","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.iac.2020.03.003_bib152","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","article-title":"Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients","volume":"155","author":"Gobert","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2020.03.003_bib153","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Autoimmune Disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.iac.2020.03.003_bib154","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \"activated PI3Kdelta syndrome\"-targeted therapy with the PI3Kdelta inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.iac.2020.03.003_bib155","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib156","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/00365540600978955","article-title":"Common variable immune deficiency and lung transplantation","volume":"39","author":"Burton","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.iac.2020.03.003_bib157","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","volume":"135","author":"Wehr","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib158","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MCP.0b013e3283642c47","article-title":"Common variable immunodeficiency-associated granulomatous and interstitial lung disease","volume":"19","author":"Prasse","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.iac.2020.03.003_bib159","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10875-015-0172-2","article-title":"Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies","volume":"35","author":"Milito","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.003_bib160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-015-0227-4","article-title":"Magnetic resonance imaging may be a valuable radiation-free technique for lung pathologies in patients with primary immunodeficiency","volume":"36","author":"Arslan","year":"2016","journal-title":"J\u00a0Clin Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856120300151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856120300151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:43:47Z","timestamp":1760179427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856120300151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":160,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0889856120300151"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2020.03.003","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Lung Disease in Primary Antibody Deficiency","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}